Nucleocapsid Protein as Early Diagnostic Marker for SARS

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Che, Xiao-Yan ; Hao, Wei ; Wang, Yadi ; Di, Biao ; Yin, Kai ; Xu, Yin-Chao ; Feng, Chang-Sen ; Wan, Zhuo-Yue ; Cheng, Vincent C.C. ; Yuen, Kwok-Yung
• Description:
  Serum samples from 317 patients with patients with severe acute respiratory syndrome (SARS) were tested for the nucleocapsid (N) protein of SARS-associated coronavirus, with sensitivities of 94% and 78% for the first 5 days and 6-10 days after onset, respectively. The specificity was 99.9%. N protein can be used as an early diagnostic maker for SARS.
• Subjects:
  Antibodies, Viral Biological Markers Dispatch Humans Nucleocapsid Protein, Monoclonal Antibody, Enzyme-linked Immunosorbent Assay, Early Diagnosis, Severe Acute Respiratory Syndrome, Dispatch Nucleocapsid Proteins SARS-CoV SARS Virus Severe Acute Respiratory Syndrome Time Factors
• Source:
  Emerg Infect Dis. 10(11):1947-1949.
• Document Type:
  Journal Article
• Volume:
  10
• Issue:
  11
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:a212c5e872e2470d916efa7400fcb8edd3654ca40995a256450392a6141e6144
• Download URL:
  https://stacks.cdc.gov/view/cdc/14683/cdc_14683_DS1.pdf
• File Type:
  [PDF - 279.72 KB ]